About GRASTOFIL

GRASTOFIL is a medication used to stimulate the production of white blood cells in patients undergoing chemotherapy or experiencing severe neutropenia. It contains the active ingredient Filgrastim, a recombinant DNA-derived human granulocyte colony-stimulating factor (G-CSF).

Key Benefits & Uses

Reduces the risk of infection in patients with neutropenia
Shortens the duration of neutropenia and its associated complications
Supports the recovery of white blood cell counts in patients undergoing chemotherapy

Active Ingredient & Action

Filgrastim works by stimulating the bone marrow to produce more white blood cells, specifically neutrophils. It binds to specific receptors on the surface of neutrophil precursors, triggering a cascade of events that leads to increased production and release of mature neutrophils into the bloodstream.

Important Notes

GRASTOFIL should only be used under the guidance of a qualified healthcare professional. Patients should be closely monitored for signs of bone pain, splenomegaly, or other adverse effects. It is essential to follow the recommended dosage and administration schedule to minimize the risk of complications.